77 related articles for article (PubMed ID: 33013060)
1. Chronic Kidney Disease and Hypertension with Reference to COVID-19.
Rathi M; Jeloka T; Prasad N; Bansal S; Agarwal SK; Bhalla AK;
Indian J Nephrol; 2020; 30(3):155-157. PubMed ID: 33013060
[No Abstract] [Full Text] [Related]
2. COVID-19 and the Kidneys: An Update.
Benedetti C; Waldman M; Zaza G; Riella LV; Cravedi P
Front Med (Lausanne); 2020; 7():423. PubMed ID: 32793615
[TBL] [Abstract][Full Text] [Related]
3. Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria.
Okoye JO
Med J Islam Repub Iran; 2020; 34():61. PubMed ID: 32974227
[No Abstract] [Full Text] [Related]
4. Hypertension Treatment for Patients with Advanced Chronic Kidney Disease.
Sinha AD; Agarwal R
Curr Cardiovasc Risk Rep; 2014 Oct; 8(10):. PubMed ID: 25544866
[TBL] [Abstract][Full Text] [Related]
5. COVID 19 and Acute Kidney Injury.
Prasad N; Agrawal SK;
Indian J Nephrol; 2020; 30(3):161-165. PubMed ID: 33013062
[TBL] [Abstract][Full Text] [Related]
6. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19.
Covino M; De Matteis G; Burzo ML; Santoro M; Fuorlo M; Sabia L; Sandroni C; Gasbarrini A; Franceschi F; Gambassi G;
Intern Med J; 2020 Dec; 50(12):1483-1491. PubMed ID: 33022124
[TBL] [Abstract][Full Text] [Related]
8. Interpreting, analysing and modelling COVID-19 mortality data.
Sornette D; Mearns E; Schatz M; Wu K; Darcet D
Nonlinear Dyn; 2020; 101(3):1751-1776. PubMed ID: 33020681
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review.
Hegde S; Khan R; Zordok M; Maysky M
Open Heart; 2020 Oct; 7(2):. PubMed ID: 33020258
[TBL] [Abstract][Full Text] [Related]
10. Association of smoking status with outcomes in hospitalised patients with COVID-19.
Adrish M; Chilimuri S; Mantri N; Sun H; Zahid M; Gongati S; Fortuzi K; Jog AP; Purmessur P; Singhal R
BMJ Open Respir Res; 2020 Oct; 7(1):. PubMed ID: 33020114
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids.
Siniorakis E; Arvanitakis S; Sfakianaki T; Katsianis A; Sinaniotis A; Papagiannopoulou V
J Allergy Clin Immunol; 2020 Dec; 146(6):1457. PubMed ID: 33019963
[No Abstract] [Full Text] [Related]
12. Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis.
Miller LE; Bhattacharyya R; Miller AL
Medicine (Baltimore); 2020 Oct; 99(40):e22439. PubMed ID: 33019426
[TBL] [Abstract][Full Text] [Related]
13. Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19.
Kavanagh O; Marie Healy A; Dayton F; Robinson S; O'Reilly NJ; Mahoney B; Arthur A; Walker G; Farragher JP
Med Hypotheses; 2020 Oct; 143():110110. PubMed ID: 33017904
[TBL] [Abstract][Full Text] [Related]
14. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
[TBL] [Abstract][Full Text] [Related]
15. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients.
Liotta EM; Batra A; Clark JR; Shlobin NA; Hoffman SC; Orban ZS; Koralnik IJ
Ann Clin Transl Neurol; 2020 Nov; 7(11):2221-2230. PubMed ID: 33016619
[TBL] [Abstract][Full Text] [Related]
16. Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports.
Lazzari G; Chiara Resta E; Magli M; D'Ettorre E; Silvano G
Clin Transl Radiat Oncol; 2020 Nov; 25():107-111. PubMed ID: 33015379
[TBL] [Abstract][Full Text] [Related]
17. The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania.
Barbu MG; Thompson RJ; Thompson DC; Cretoiu D; Suciu N
Front Med (Lausanne); 2020; 7():567199. PubMed ID: 33015111
[No Abstract] [Full Text] [Related]
18. What Can We Estimate From Fatality and Infectious Case Data Using the Susceptible-Infected-Removed (SIR) Model? A Case Study of Covid-19 Pandemic.
Ahmetolan S; Bilge AH; Demirci A; Peker-Dobie A; Ergonul O
Front Med (Lausanne); 2020; 7():556366. PubMed ID: 33015109
[TBL] [Abstract][Full Text] [Related]
19. A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.
Benskin LL
Front Public Health; 2020; 8():513. PubMed ID: 33014983
[TBL] [Abstract][Full Text] [Related]
20. Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
Ramtohul T; Cabel L; Paoletti X; Chiche L; Moreau P; Noret A; Vuagnat P; Cherel P; Tardivon A; Cottu P; Bidard FC; Servois V
Front Oncol; 2020; 10():1560. PubMed ID: 33014804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
